CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-01-28 | Vasista Vittal | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2016-01-28 | Mills Kenneth T. President and CEO | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2016-01-28 | Simpson Curran | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2015-10-14 | STUMP DAVID C Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2015-09-22 | Flynn James E 10% owner | Conversion | +771,963 | 771,963 | ||
| 2015-09-22 | Flynn James E 10% owner | Conversion | +397,079 | 1,169,042 | ||
| 2015-09-22 | Flynn James E 10% owner | Purchase | +87,500 | $22.00 | $1.9M | 1,256,542 |
| 2015-09-22 | Flynn James E 10% owner | Purchase | +38,500 | $22.00 | $847K | 38,500 |
| 2015-09-22 | Flynn James E 10% owner | Purchase | +49,000 | $22.00 | $1.1M | 49,000 |
| 2015-09-22 | Flynn James E 10% owner | Conversion · Series C Convertible Preferred Stock | −771,963 | 0 | ||
| 2015-09-22 | Flynn James E 10% owner | Conversion · Series D Convertible Preferred Stock | −397,079 | 0 | ||
| 2015-09-22 | Vasista Vittal | Conversion | +15,440 | 115,440 | ||
| 2015-09-22 | Vasista Vittal | Conversion · Series C Preferred Stock | −15,440 | 0 | ||
| 2015-09-22 | HAYDEN DONALD J JR Director | Conversion | +38,599 | 38,599 | ||
| 2015-09-22 | HAYDEN DONALD J JR Director | Conversion · Series C Preferred Stock | −38,599 | 0 | ||
| 2015-09-22 | ENGLEMAN EDGAR Director | Conversion | +826,341 | 826,341 | ||
| 2015-09-22 | ENGLEMAN EDGAR Director | Conversion | +114,108 | 114,108 | ||
| 2015-09-22 | ENGLEMAN EDGAR Director | Conversion · Series D Preferred Stock | −826,341 | 0 | ||
| 2015-09-22 | ENGLEMAN EDGAR Director | Conversion · Series D Preferred Stock | −114,108 | 0 | ||
| 2015-09-22 | Mills Kenneth T. Director | Conversion | +15,440 | 15,440 |
Page 55 of 56 · 1,104 trades